Alexion Pharmaceuticals, Inc.

CAPSTONE INVESTMENT ADVISORS, LLC ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

2/11/2022

Shares

868,549

Value ($000)

159,561

Weight

3.8%

2019 Q4 - 2021 Q2 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	2/11/2022	159,561	3.8%	868,549	6/30/2021
2021 Q1	2/11/2022	180,051	5.5%	1,177,499	3/31/2021
2020 Q4	6/21/2021	30,942	1.0%	198,044	12/31/2020
2019 Q4	6/21/2021	2,015	0.1%	18,634	12/31/2019